Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Safety and efficacy of isatuximab plus bortezomib, lenalidomide, and dexamethaso...
Dr Enrique Ocio - Marqués de Valdecilla University Hospital, Santander, Spain
14 Sep 2021
Multidisciplinary management of ovarian germ cell tumours - a single institution...
Dr Sandip Ganguly - Tata Medical Center, Kolkata, India
14 Sep 2021
Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or car...
Prof Sagar Lonial - Winship Cancer Institute of Emory University, Atlanta, USA
14 Sep 2021
Should every transplant eligible NDMM patient receive a transplant?
Prof Morie Gertz - Mayo Clinic, Rochester, USA
14 Sep 2021
Disparities in myeloma: Closing the gap
Prof Joseph Mikhael - Translational Genomics Research Institute, Pheonix, USA
10 Sep 2021
Suboptimal humoral immune response to COVID-19 vaccination in myeloma patients
Dr Oliver Van Oekelen - Icahn School of Medicine at Mount Sinai, New York City, ...
10 Sep 2021
Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-ta...
Dr Oliver Van Oekelen - Icahn School of Medicine at Mount Sinai, New York City, ...
10 Sep 2021
Retrospective analysis of COVID-19 infection in 371 Czech multiple myeloma patie...
Dr Jakub Radocha - Charles University, Prague, Czech Republic
10 Sep 2021
Idecabtagene vicleucel for relapsed and refractory multiple myeloma
Prof Larry Anderson - UT Southwestern Medical Center, Dallas, USA
10 Sep 2021
OncoAlert and ecancer weekly round up for August 23rd - August 29th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
31 Aug 2021
Culture, Community and Communication in Advanced Disease in India
Dr Dwai Banerjee - Massachusetts Institute of Technology, Boston, USA
26 Aug 2021
OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
23 Aug 2021
